Centauri welcomes Dr Rinki Deb

October 2, 2022 | Updates
Centauri is delighted to welcome Dr Rinki Deb to the team at Alderley Park. Rinki joins Centauri to take up the post of project manager and brings a wealth of experience from her time at the Liverpool School of Tropical Medicine.

Centauri welcomes Dr Hassan Al-Bewani

July 18, 2022 | Updates
Centauri welcomes Dr Hassan Al-Bewani who joins the scientific team as senior immunologist. Hassan previously worked for the UK Health Security Agency and was awarded…

Centauri strengthens senior leadership team with three key appointments

July 12, 2022 | Updates
Centauri is pleased to announce that Jennifer Schneider, Helen Bright and David Roblin have joined the senior leadership team.  Please see this press release for…
Aisha Baba Dikwa headshot

Centauri welcomes Dr Aisha Baba Dikwa

June 20, 2022 | Updates
Centauri welcomes Dr Aisha Baba Dikwa who joins the scientific team as senior microbiologist.

Centauri welcomes scientists to the team

June 1, 2022 | Updates
Centauri is delighted to welcome Bailey Hairsine and Sana Mobeen to the scientific team. Reporting to Dr Helen Bright, Bailey and Sana will undertake in vitro research…
Arial shot of Centauri's lab at Alderley Park

Centauri opens lab at Alderley Park

May 1, 2022 | Updates
Centauri Therapeutics has taken a laboratory lease on Alderley Park and looks forward to research operations commencing shortly.

Centauri story featured in Sunday Times

March 20, 2022 | News
Centauri's story through an interview with CSO Dr Mike Westby was featured in a Sunday Times article written by Sabah Meddings.

Centauri awarded follow-on CARB-X grant

February 22, 2022 | News
Centauri Therapeutics Limited, an immunotherapy company focused on the treatment of infectious diseases, has been awarded a grant of up to $2.7 million USD (c.£2…
A medical image

Centauri welcomes Dr Mike Westby, Chief Scientific Officer and Pamela Brown, Head of Chemistry

February 1, 2022 | Updates
Following the recent investment announcement, Centauri is pleased to announce that Mike Westby and Pam Brown have joined Centauri Therapeutics. Mike is now Centauri’s Chief…

Centauri Therapeutics closes £24m Series A investment round

January 26, 2022 | News
Centauri Therapeutics is delighted to announce new investment of £24m in antimicrobial research and appointment of new company directors. See attached press release